Dr. Charles Alessi
Dr. Charles Alessi
P: +44 7879848678
E-mail: alessicws@gmail.com
Appointments
Research Cluster Membership
- Ageing and Life course epidemiology
- Chronic Disease & Multimorbidity
- Behavioural and Environmental Risk factors
- Global Health
Research Interests
- Ageing and dementia risk reduction
- Personalisation and precision health
- Behavioural science and their deployment within health systems
Short Bio
Dr. Charles Alessi is chief clinical officer of editohealth, a content creation agency whose ambition is to stimulate digital health adoption around the world by creating engaging content, facilitating peer to peer sharing of best practices, and more efficiently matchmaking buyers, procurers, investors and suppliers.
My role is to guide the development of content and other activities that are specifically targeting clinicians and health and care professionals, and empowering them to become digital leaders of a healthy and sustainable future.
As a globally recognised and trusted leader in health care, I bring a wealth of experience around implementation and deployment of health systems with a particular focus on the use of new blended approaches in delivering health and care, and the interface between healthcare, social care and the personalisation of health and medicine.
I am a physician in London with more than 35 years of experience in all aspects of policy and clinical practice in the UK and globally. Previous major roles include global chief clinical officer at HIMSS, senior advisor to Public Health England, Chairman of the National association of primary care, and member of WHO expert panels around the neurosciences and dementia risk reduction. In these capacities, I have led initiatives around personalisation of health in England working at the most senior levels, and internationally, assisting governments and corporations deploy new initiatives. I have also worked extensively with patient organisations assisting them in being better heard, and refining their messaging to members.
I am also currently advising the President of the International Association of Public Health Institutes (IANPHI) as well as the new public health agency (Weqaya) in the Kingdom of Saudi Arabia.
I am part of the expert advisory panel set up by WHO to refresh the global guidelines towards Dementia risk reduction due to be published towards the end of 2024 or early 2025
I have recently been appointed as associate lecturer in medicine at the medical faculty at Anglia Ruskin University in East Anglia, England and as adjunct research professor in Biostatistics and Epidemiology at the Schulich School of Medicine and Dentistry at the University of Western Ontario, Canada.
I sit on advisory boards of medical technology companies and have published very widely in academic and popular journals, as well as co-authoring a book on helping people better manage their risk factors in reducing their risk of cognitive decline (“Increase your Brainability and reduce your risk of dementia” published by Oxford University press)
